Highlighting the immunohistochemical profile of melanocytomas (review)

Oncology Reports

Volumn 19, Issue 6, 2008, Pages 1367-1372

  Quatresooz, Pascale ^a   Piérard Franchimont, Claudine ^a   Piérard, Gérald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Melanocytoma; Melanoma; Prognostic factor; Risk stratification; Spitzoid tumor

Indexed keywords

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER GROWTH; CANCER RISK; CELL PROLIFERATION; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; MELANOCYTOSIS; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; ENZYME IMMUNOASSAY; PATHOLOGY; PIGMENTED NEVUS; REVIEW; SKIN TUMOR;

HUMANS; IMMUNOENZYME TECHNIQUES; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 48849098320     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Smoller BR: Histologic criteria for diagnosing primary cutaneous malignant melanoma. Modern Pathol 19: 34-40, 2006.
2. Darier J and Civatte A: Naevus ou naevo-carcinome chez un nourisson. Bull Soc Franc Derm Syph 21: 61-63, 1910.
3. Barnhill RL: The spitzoid lesion: rethinking Spitz tumors, atypical variants, 'spitzoid melanoma' and risk assessment. Modern Pathol 19: S21-S33, 2006.
4. Quatresooz P, Arrese JE, Piérard-Franchimont C and Piérard GE: Immunohistochemical aid at risk stratification of melanocytic neoplasms. Int J Oncol 24: 211-216, 2004.
5. Moi WJ and Krausz T: Spitz nevus versus spitzoid melanoma. Diagnostic difficulties, conceptual controversies. Adv Anat Pathol 13: 147-156, 2006.
6. Farmer ER and Gonin R: Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 27: 528-531, 1996.
7. Grant-Kels JM, Bason ET and Grin CM: The misdiagnosis of malignant melanoma. J Am Acad Dermatol 4: 539-548, 1999.
8. Brochez L, Verhaeghe E, Grosshans E, et al: Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 196: 459-466, 2002.
9. Cook MG: Diagnostic pitfalls with melanocytic tumours. Curr Diagn Pathol 10: 463-472, 2004.
10. Ainsworth AM, Folberg R, Reed RJ and Clark WH: Melanocytic Nevi, Melanocytomas, Melanocytic Dysplasias and Uncommon Forms of Melanoma. In: Human Malignant Melanoma: Clinical Oncology Monographs. Clark WH, Goldman KI and Mastrangelo MJ (eds). Grime & Stratton, New York, pp167-208, 1979.
11. Reed RJ: Minimal deviation melanoma. Hum Pathol 21: 1206-1211, 1990.
12. Barnhill RL, Flotte TJ, Fleischli M and Perez-Atayde A: Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer 76: 1833-1845, 1995.
13. Reed RJ: Dimensionalities: Bordeline and intermediate melanocytic neoplasia. Hum Pathol 30: 521-524, 1999.
14. Gurbuz Y, Apaydin R, Muezzinoglu B and Buyukbabani N: A case report and a current dilemma in histopathology: atypical Spitz nevus or spitzoid melanoma. Pediatr Dermatol 19: 99-102, 2002.
15. Mones JM and Ackerman AB: 'Atypical' Spitz's nevus, 'malignant' Spitz's nevus, and 'metastasizing' Spitz's nevus: A critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol 26: 310-333, 2004.
16. Lee JB: Spitz nevus versus melanoma: limitation of the diagnostic methodology exposed. Eur J Dermatol 16: 223-224, 2006.
17. Piérard GE, Piérard-Franchimont C, Nikkels AF, et al.: Naevocyte triggering by recombinant human growth hormone. J Pathol 180: 74-79, 1996.
18. Onsun N, Saracoglu S, Demirkesen C, et al: Eruptive widespread Spitz nevi: can pregnancy be a stimulating factor? J Am Acad Dermatol 40: 866-867, 1999.
19. Sabroe RA, Vaingankar NV, Rigby HS and Peachey RD: Agminate Spitz naevi occurring in an adult after the excision of a solitary Spitz naevus: Report of a case and review of the literature. Clin Exp Dermatol 21: 197-200, 1996.
20. Ball NJ and Golitz LE: Melanocytic naevi with focal atypical epithelioid cell components: a review of seventy-three cases. J Am Acad Dermatol 40: 724-729, 1994.
21. Collina G, Deen S, Cliff S, et al: Atypical dermal nodules in benign melanocytic naevi. Histopathology 31: 97-101, 1997.
22. Quatresooz P, Uhoda I, Fumal I, et al: Revisiting the gender-linked melanoma burden. Dermatology 209: 197-201, 2004.
23. Uhoda I, Quatresooz P, Fumal I, et al: Updating trends in cutaneous cancers in south-east Belgium. Oncol Rep 12: 111-114, 2004.
24. Orchard DC, Dowling JP and Kelly JW: Spitz naevi misdiagnosed histologically as melanoma: prevalence and clinical profile. Aust J Dermatol 38: 12-14, 1997.
25. Barnhill RL, Argenyi ZB, From L, et al: Atypical Spitz nevi/ tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 30: 513-520, 1999.
26. Alonso SR, Ortiz P, Pollan M, et al: Progression in cutaneous malignant melanoma is associated with distinct expression profiles. A tissue microarray-based study. Am J Pathol 164: 193-203, 2004.
27. Coulson A, Ross JS, Slominski A, et al: Molecular diagnostics in melanoma. J Am Acad Dermatol 52: 743-775, 2005.
28. Claessens N, Piérard GE, Piérard-Franchimont C, et al: Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement. Melanoma Res 15: 107-110, 2005.
29. Crowson N, Magro CM and Mihm MC: Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Modern Pathol 10: S71-S87, 2006.
30. Piérard-Franchimont C, Henry F, Heymans O and Piérard GE: Vascular retardation in dormant growth-stunted malignant melanomas. Int J Mol Med 4: 403-406, 1999.
31. Kanter-Lewensohn L, Hedblad MA, Wejde J and Llqarsson O: Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod Pathol 10: 917-920, 1997.
32. Mangini J, Li N and Bhawan J: Immunohistochemical markers of melanocytic lesions. A review of their diagnostic usefulness. Am J Dermatopathol 24: 270-281, 2002.
33. + T lymphocytes and L1-protein + macrophages in primary cutaneous melanomas. Int J Mol Med 2: 721-724, 1998.
34. Piérard-Franchimont C, Arrese JE, Nikkels AF, et al: Factor XIIIa-positive dermal dendrocytes and proliferative activity of cutaneous cancers. Virchows Arch 429: 43-48, 1996.
35. Quatresooz P and Piérard GE: Immunohistochemical investigation of α1 (IV) and α5 (IV) collagen chains in a broad spectrum of melanocytic tumours. Melanoma Res 15: 161-168, 2005.
36. Bergman R, Dromi R, Trau H, et al: The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol 17: 542-546, 1995.
37. Piérard GE, Piérard-Franchimont C, Henry C and Lapière M: The proliferative activity of cells of malignant melanomas. Am J Dermatopathol 6: S317-S324, 1984.
38. Spatz A, Calonje E, Handfield-Johnes S, et al: Spitz tumors in children: a grading system for risk stratification. Arch Dermatol 135: 282-285, 1999.
39. Walsh N, Crotty K, Palmer A, et al: Spitz nevus versus spitzoid malignant melanoma: An evaluation of the current distinguishing histopathologic criteria. Hum Pathol 29: 1105-1112, 1998.
40. Li LX, Crotty KA, McCarthy SW, et al: A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol 22: 489-495, 2000.
41. Bergman R, Malkin L, Sabo E, et al: MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to histopathologic differential diagnosis of Spitz nevi. J Am Acad Dermatol 44: 500-504, 2001.
42. Vollmer RT: Use of Bayes rule and MIB-1 proliferation index to discriminate Spitz nevus from malignant melanoma. Am J Clin Pathol 122: 499-505, 2004.
43. Kapor P, Selim MA, Roy LC, et al: Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod Pathol 18: 197-204, 2005.
44. Sprecher E, Bergman R, Meilick A, et al: Apoptosis, Fas and Fas-ligand expression in melanocytic tumors. Cutan Pathol 26: 72-77, 1999.
45. Hussein M, Haemel A and Wood ES: Apoptosis and melanoma: molecular mechanisms. J Pathol 199: 275-288, 2003.
46. Piérard GE and Piérard-Franchimont C: Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur J Cancer 33: 1888-1892, 1997.
47. Heymans O, Blacher S, Brouers F and Piérard GE: Fractal quantification of the microvasculature heterogeneity in cutaneous melanoma. Dermatology 198: 212-217, 1999.
48. Bayer-Garner IB, Hough AJ and Smoller BR: Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness. Mod Pathol 12: 770-774, 1999.
49. Cockerell CJ, Sonnier G, Kelly L and Patel S: Comparative analysis of neovascularization in primary cutaneous melanoma and Spitz nevus. Am J Dermatopathol 16: 9-13, 1994.
50. Diaz-Cascajo C, Borghi S and Weyers W: Angiomatoid Spitz nevus: a distinct variant of desmoplastic Spitz nevus with prominent vasculature. Am J Dermatopathol 22: 135-139, 2000.